PHI with Insulin-dependent diabetes
How does this condition affect your private health insurance?
Insulinabhängiger Diabetes, also known as Type 1 Diabetes Mellitus, is a chronic autoimmune condition where the body's immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. This leads to a severe deficiency or complete lack of insulin, a hormone essential for glucose uptake by cells. Without insulin, blood sugar levels rise dangerously high, a condition called hyperglycemia. It typically develops in children and young adults but can occur at any age. Symptoms include excessive thirst, frequent urination, unexplained weight loss, and fatigue. Lifelong insulin therapy is crucial for survival and managing blood glucose levels to prevent acute and long-term complications.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute onset, often presenting over days to weeks with severe symptoms.
Duration of Illness (Lifetime)
Chronic, lifelong condition requiring continuous management.
Cost of Treatment (Initial)
High, including hospitalization, diagnostic tests, initial insulin regimen, and education.
Cost of Treatment (Lifetime)
Very high, encompassing daily insulin, syringes/pens or pump supplies, blood glucose monitoring equipment, continuous glucose monitors (CGMs), regular doctor visits, and potential treatment for complications.
Mortality Rate
Low with consistent and proper medical management; significantly high if untreated or poorly controlled due to acute complications like DKA or severe long-term complications.
Risk of Secondary Damages
High, especially with suboptimal management. Potential complications include diabetic retinopathy (eye damage), nephropathy (kidney disease), neuropathy (nerve damage), cardiovascular disease (heart attacks, strokes), and foot problems.
Probability of Full Recovery
Extremely low to none; Type 1 Diabetes is an autoimmune destruction of beta cells, making complete recovery currently impossible without pancreatic or islet cell transplantation, which comes with its own risks.
Underlying Disease Risk
Increased probability of other autoimmune conditions, such as celiac disease, thyroid disorders (Hashimoto's thyroiditis, Graves' disease), Addison's disease, and pernicious anemia.